BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37935735)

  • 21. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
    Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
    [No Abstract]   [Full Text] [Related]  

  • 22. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
    Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score.
    Jiang W; Zeng ZC; Tang ZY; Fan J; Sun HC; Zhou J; Zeng MS; Zhang BH; Ji Y; Chen YX
    Ann Oncol; 2011 Jul; 22(7):1644-1652. PubMed ID: 21212156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
    Li XH; Zhao CY; Zhou EL; Lin XJ
    BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The analysis of long-term prognostic factors after laparoscopic liver resection for intrahepatic cholangiocarcinoma and establishment of survival Nomogram model].
    Shen ZF; Chen C; Geng ZM; Mao XH; Li JD; Song TQ; Sun CD; Wu H; Cheng ZJ; Lin RX; He Y; Zhai WL; Tang D; Tang ZH; Liang X
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):939-947. PubMed ID: 36207983
    [No Abstract]   [Full Text] [Related]  

  • 27. Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma.
    Shirai K; Ebata T; Oda K; Nishio H; Nagasaka T; Nimura Y; Nagino M
    World J Surg; 2008 Nov; 32(11):2395-402. PubMed ID: 18795245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study.
    Qiang Z; Zhang W; Jin S; Dai K; He Y; Tao L; Yu H
    Ann Hepatol; 2021; 20():100242. PubMed ID: 32841741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment.
    Ishimoto U; Kondo S; Ohba A; Sasaki M; Sakamoto Y; Morizane C; Ueno H; Okusaka T
    Oncology; 2018; 94(2):72-78. PubMed ID: 29017161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
    Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
    Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study.
    Zhou YW; Li QF; Chen YY; Wang K; Pu D; Chen XR; Li CH; Jiang L; Wang Y; Li Q; Yang Y; Gou HF; Bi F; Liu JY; Chen Y; Qiu M
    Eur J Surg Oncol; 2022 Jul; 48(7):1559-1566. PubMed ID: 35115213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma.
    Buettner S; Galjart B; van Vugt JLA; Bagante F; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Groot Koerkamp B; Pawlik TM
    J Surg Oncol; 2017 Dec; 116(8):1085-1095. PubMed ID: 28703880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth.
    Kajiyama K; Maeda T; Takenaka K; Sugimachi K; Tsuneyoshi M
    Am J Surg Pathol; 1999 Aug; 23(8):892-902. PubMed ID: 10435558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of pre- and postoperative tumor markers in patients with intrahepatic cholangiocarcinoma.
    Okada K; Kobayashi T; Kuroda S; Mashima H; Hashimoto M; Tahara H; Ohira M; Uemura K; Takahashi S; Ohdan H
    Surg Today; 2024 Feb; 54(2):177-185. PubMed ID: 37340141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery.
    Park HM; Yun SP; Lee EC; Lee SD; Han SS; Kim SH; Park SJ
    Ann Surg Oncol; 2016 Dec; 23(13):4392-4400. PubMed ID: 27581609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.